BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38518055)

  • 21. Rare malignant ulcer related to primary intestinal diffuse large B-cell lymphoma: A case report.
    Jia N; Tang Y; Li Y
    Medicine (Baltimore); 2020 Feb; 99(6):e18590. PubMed ID: 32028388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Rupture of hepatic lesion of diffuse large B-cell lymphoma following immunochemotherapy].
    Segawa R; Natazuka T
    Rinsho Ketsueki; 2022; 63(3):211-216. PubMed ID: 35387935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synchronous gastric cancer and primary lymphoma of right adrenal gland: a case report.
    Fukuda S; Wakasa T; Hanamoto H; Koyama T; Ohta Y; Inoue M; Terashita D; Gakuhara A; Tomihara H; Ohta K; Kitani K; Hashimoto K; Ishikawa H; Hida JI; Kimura Y
    Clin J Gastroenterol; 2021 Oct; 14(5):1350-1357. PubMed ID: 34283402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary diffuse large B-cell lymphoma of the Larynx.
    Higo R; Kojima M; Itoh S; Noguchi M; Izumi H; Takeuchi K
    Auris Nasus Larynx; 2023 Aug; 50(4):632-636. PubMed ID: 35863932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary breast lymphoma - a case report.
    Rajabto W; Angkasa YK; Harahap AS; Ham MF; Brahma B
    Klin Onkol; 2021; 34(6):477-480. PubMed ID: 34911334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathological analysis of primary refractory diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone chemoimmunotherapy.
    Suzuki T; Maruyama D; Miyagi-Maeshima A; Nomoto J; Tajima K; Ito Y; Hatta S; Yuda S; Makita S; Fukuhara S; Munakata W; Suzuki T; Taniguchi H; Izutsu K; Kobayashi Y; Tobinai K
    Cancer Med; 2021 Aug; 10(15):5101-5109. PubMed ID: 34105893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicenter Phase 2 Study of Reduced-Dose CHOP Chemotherapy Combined With Rituximab for Elderly Patients With Diffuse Large B-Cell Lymphoma.
    Park S; Jo JC; Do YR; Yang DH; Lim SN; Lee WS; Kim WS; Lee HS; Hong DS; Kim HJ; Shin HJ
    Clin Lymphoma Myeloma Leuk; 2019 Mar; 19(3):149-156. PubMed ID: 30581162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chidamide combined with ibrutinib improved the prognosis of primary bone marrow diffuse large B cell lymphoma.
    Tian C; Chen Z; Li Y
    J Int Med Res; 2020 Jul; 48(7):300060520936053. PubMed ID: 32643971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pegylated liposomal doxorubicin replacing conventional doxorubicin in standard R-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma: an open label, single arm, phase II trial.
    Oki Y; Ewer MS; Lenihan DJ; Fisch MJ; Hagemeister FB; Fanale M; Romaguera J; Pro B; Fowler N; Younes A; Astrow AB; Huang X; Kwak LW; Samaniego F; McLaughlin P; Neelapu SS; Wang M; Fayad LE; Durand JB; Rodriguez MA
    Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):152-8. PubMed ID: 25445468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3A Comparison between R-THP-COP and R-CHOP Regimens for the Treatment of Diffuse Large B-cell Lymphoma in Old Patients: A Single-institution Analysis.
    Araie H; Sakamaki I; Matsuda Y; Tai K; Ikegaya S; Itoh K; Kishi S; Oiwa K; Okura M; Tasaki T; Hosono N; Ueda T; Yamauchi T
    Intern Med; 2017 Sep; 56(18):2407-2413. PubMed ID: 28824057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi.
    Chiappella A; Tucci A; Castellino A; Pavone V; Baldi I; Carella AM; Orsucci L; Zanni M; Salvi F; Liberati AM; Gaidano G; Bottelli C; Rossini B; Perticone S; De Masi P; Ladetto M; Ciccone G; Palumbo A; Rossi G; Vitolo U;
    Haematologica; 2013 Nov; 98(11):1732-8. PubMed ID: 23812930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treating Diffuse Large B Cell Lymphoma in the Very Old or Frail Patients.
    Kumar A; Fraz MA; Usman M; Malik SU; Ijaz A; Durer C; Durer S; Tariq MJ; Khan AY; Qureshi A; Faridi W; Nasar A; Anwer F
    Curr Treat Options Oncol; 2018 Sep; 19(10):50. PubMed ID: 30173370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pattern of failure and optimal treatment strategy for primary gastric diffuse large B-cell lymphoma treated with R-CHOP chemotherapy.
    Kang HJ; Lee HH; Jung SE; Park KS; O JH; Jeon YW; Choi BO; Cho SG
    PLoS One; 2020; 15(9):e0238807. PubMed ID: 32960887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrospective analysis of frontline treatment efficacy in elderly patients with diffuse large B-cell lymphoma.
    Cheng CL; Liu JH; Chou SC; Yao M; Tang JL; Tien HF
    Eur J Haematol; 2018 Jul; 101(1):28-37. PubMed ID: 29603428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte.
    Feugier P; Van Hoof A; Sebban C; Solal-Celigny P; Bouabdallah R; Fermé C; Christian B; Lepage E; Tilly H; Morschhauser F; Gaulard P; Salles G; Bosly A; Gisselbrecht C; Reyes F; Coiffier B
    J Clin Oncol; 2005 Jun; 23(18):4117-26. PubMed ID: 15867204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary cardiac lymphoma: clinical, histologic, immunophenotypic, and genotypic features of 5 cases of a rare disorder.
    Nascimento AF; Winters GL; Pinkus GS
    Am J Surg Pathol; 2007 Sep; 31(9):1344-50. PubMed ID: 17721189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case report of primary prostate intravascular large B cell lymphoma presenting as prostatic hyperplasia.
    Zhu F; Pan H; Xiao Y; Li Q; Liu T; Liu X; Wu G; Li J; Zhang L
    Medicine (Baltimore); 2019 Dec; 98(50):e18384. PubMed ID: 31852153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary diffuse large B cell lymphoma (DLBCL) of the prostate presenting with lower urinary tract symptoms (LUTS).
    Nusrat A; Nazim SM
    BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33370963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hitting back at lymphoma: How do modern diagnostics identify high-risk diffuse large B-cell lymphoma subsets and alter treatment?
    Abramson JS
    Cancer; 2019 Sep; 125(18):3111-3120. PubMed ID: 31287161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complete remission of primary cutaneous intravascular large B-cell lymphoma with R-CHOP followed by rituximab monotherapy.
    Pantelaki I; Tigges C; Nußbaum T; Oellig F; Wieland U; Kreuter A
    Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28508527
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.